№2 / 2009

EDITORIAL
Acute glomerulonephritis –all questions are answered? 		4-9
HOTLINE TOPIC
N.A. Moukhin, MD, PhD, Prof
Signs, mimicking chronic glomerulonephritis activity 		10-16
STATE-OF-ART
G.E. Gendlin, MD, PhD, Prof; O.A. Ettinger, MD, Ass Prof; E.V. Resnyk, MD; O.A. Tronina, MD; O.A. Solomonova, MD
Ultrasound scanning of kidney: opportunities and limitations 		17-25
S.V. Nedogoda, MD, PhD, Prof
Nephroprotection in metabolic syndrome 		26-30
S.V. Moiseev, MD, PhD, Prof; G.P. Arutyunov, MD, PhD, Prof; V.V. Fomin, MD, PhD
ACE inhibitors and nephroprotection in chronic proteinuric nephropathies 		31-36
PERSPECTIVE IN NEPHROLOGY
E.M. Paltseva, MD, PhD
Experimental models of chronic nephropathies 		37-42
G.P. Arutyunov, MD, PhD, Prof; L.G. Oganezova, MD
Beta-blockers and renal continuum 		43-51
ORIGINAL PAPERS
I.E. Chazova, MD, PhD, Prof; V.V. Fomin, MD, PhD; M.A. Razuvaeva, MD; A.V. Vigdorchik, MD
Russian registry of resistant arterial hypertension (“REGATTA”): study design. 		52-54
V.V. Rameev, MD; L.V. Kozlovskaya, MD, PhD, Prof; E.A. Malinina, A.G. Serova, I.N. Kogarko, MD, PhD; B.S. Kogarko, MD, PhD; N.V. Liubimova, MD, PhD
Determination of circulating amyloid precursor protein in diagnosis and monitoring of disease progression in systemic amyloidosis 		55-62
L.T. Pimenov, MD, PhD, Prof; M.V. Dudarev, MD, PhD; M.Yu. Vasil’ev, MD
Chronic kidney disease as an outcome of hemorrhagic fever with renal syndrome 		63-65
M.Yu. Shvetsov, MD, PhD; A.A. Ivanov, MD, PhD, Prof; O.P. Popova, MD; A.V. Kuznetsova, MD, PhD; A.S. Rameeva
Renal expression of hypoxia-induced factor-1, anemia and nephrosclerosis severity in chronic glomerulonephritis. 		66-70
NEPHROLOGICAL FORUM
Optimization of loop diuretic therapy in chronic heart failure and chronic kidney disease 		71-74
DISCUSSION
Membranous nephropathy: how to differentiate primary and paraneoplastic variants? 		75-78
DATE
79-79

Бионика Медиа